GeoVax Vaccine Selected to Participate in Development of Potential HIV Functional Cure

NEXT STORY
Neoleukin Therapeutics Announces Corporate Update and Third Quarter 2019 Financial Results
PREV STORY
Innovation Pharmaceuticals:  Oral Cancer on the Rise; Company Offers Perspectives on Opportunity of Brilacidin for the Prevention of Oral Mucositis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oasmia Pharmaceutical AB’s (publ, ”Oasmia”) decision to cancel the extraordinary general meeting on January 25, 2019

The proposition on a new board of directors in Oasmia presented by Arwidsro Investment ...

author_avatar
NASDAQ Market News

Merus nimmt an der 13. jährlichen Biotech-Konferenz von Citi teil

UTRECHT (Niederlande), Aug. 30, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen ...

author_avatar
NASDAQ Market News

Ultragenyx to Present at Leerink Partners Roundtable Series

NOVATO, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical ...

author_avatar
NASDAQ Market News